Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancerKUO, Timothy; CHO, Cheryl D; HALSEY, Joanne et al.Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5613-5619, issn 0732-183X, 7 p.Article

Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRnBAKER, Kristi; QIAO, Shuo-Wang; KUO, Timothy et al.Seminars in immunopathology (Print). 2009, Vol 31, Num 2, pp 223-236, issn 1863-2297, 14 p.Article

Optimizing therapy for patients with brain metastasesKUO, Timothy; RECHT, Lawrence.Seminars in oncology. 2006, Vol 33, Num 3, pp 299-306, issn 0093-7754, 8 p.Article

A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Untreated Patients with Metastatic Colorectal CancerFISHER, George A; KUO, Timothy; RAMSEY, Meghan et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 7074-7079, issn 1078-0432, 6 p.Article

The inhibitory cytokine IL-35 contributes to regulatory T-cell functionCOLLISON, Lauren W; WORKMAN, Creg J; KUO, Timothy T et al.Nature (London). 2007, Vol 450, Num 7169, pp 566-569, issn 0028-0836, 4 p.Article

IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunityYOSHIDA, Masaru; MASUDA, Atsuhiro; KUO, Timothy T et al.Springer seminars in immunopathology. 2006, Vol 28, Num 4, pp 397-403, issn 0344-4325, 7 p.Article

The effect of partial denaturation on Nd:YAG laser mediated stress relaxation of porcine septal cartilageKUO, Timothy C; KIM, Hong K; MILNER, Thomas E et al.SPIE proceedings series. 2000, pp 75-85, isbn 0-8194-3530-9Conference Paper